Pharma R&D Production Science Small Molecule 
DrugBaron
JANUARY 31, 2024
After decades slowly developing in the shadows, featuring more often in science fiction novels than television news programs, the arrival of large language models, and ChatGPT in particular, thrust artificial intelligence into the national consciousness. Does AI improve decision making in drug R&D?
Drug Discovery World
AUGUST 7, 2024
The inequality between near-zero-cost AI-driven drug discovery and skyrocketing costs for clinical trials and regulatory approval will create a bottleneck, stalling promising drugs from reaching patients unless AI is equally applied across the entire R&D lifecycle. Singhal is the company’s president; Wickramasekara its CEO.
Expert insights. Personalized for you.
165 
Let's personalize your content